After Hours
$
4.04
Change
+0.03 +0.75%
Volume
Volume 505,613
Mar 1, 2021, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 5.71
$ 4.01
Change
-1.70 -29.77%
Day low
Day high
$3.91
$5.30

52 week low
52 week high
$0.80
$6.25

Market cap
$1.41B
Average volume
6.14M
P/E ratio
N/A
Rev. per Employee
$270,307
EPS
-0.25
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on MNKD
-
MannKind started at outperform with $3 stock price target at SVB Leerink
- Tomi Kilgore
-
Why Investors Should Cash Out Of This Soaring Biotech Stock
- Barron's Online
-
MacroGenics Soars in the Biotech Casino
- Barron's Online
-
What to Do When Your Biotech Stock Nearly Triples in a Day
- Barron's Online
-
How to spot risky biotech companies and six to avoid now
- Michael Brush
-
MannKind's stock sinks after direct stock offering
- Tomi Kilgore
-
MannKind's stock tumbles 12% premarket after stock offering
- Tomi Kilgore
-
MannKind CEO, Exec Bought Stock in December
- Barron's Online
-
MannKind’s Cash Runway Looks Too Short
- Barron's Online
-
MannKind's stock extends slide, plunges 19% in active trade
- Tomi Kilgore
-
Morning Movers: Delta Flies on Earnings; Colgate Gains
- Barrons Blogs
-
MannKind's stock has tripled over the past 7 sessions
- Tomi Kilgore
-
MannKind's stock falls 7.9% premarket, in danger of snapping 7-session win streak
- Tomi Kilgore
-
Mannkind shares surge another 23%
- Ciara Linnane
-
This top investment newsletter is winning big on one stock
- Mark Hulbert
-
MannKind Stock Seen Reaching $7
- Barron's Online
-
- Barron's Online
- Loading more headlines...
Analyst Ratings
-
A Deep Dive Into MannKind's Big Bet On Afrezza
- Benzinga.com
-
New Label For Afrezza Could Turn Things Around At MannKind
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For October 10, 2017
- Benzinga.com
Other News on MNKD
-
SOS, MNKD, CAN and OTRK among midday movers
- Seeking Alpha
-
MannKind under pressure on $150 million worth private placement
- Seeking Alpha
-
Oppenheimer Believes MannKind (MNKD) Still Has Room to Grow
- SmarterAnalyst
-
- Edgar Online - (EDG = 10Q, 10K)
-
MannKind EPS misses by $0.01, beats on revenue
- Seeking Alpha
-
Oppenheimer Believes MannKind (MNKD) Still Has Room to Grow
- SmarterAnalyst
-
- GuruFocus.com
-
MNKD, APPS, SAVA and GOOS among premarket gainers
- Seeking Alpha
-
Oppenheimer Believes MannKind (MNKD) Still Has Room to Grow
- SmarterAnalyst
-
Final Update For My 20/20 Vision For 2020 Dividend Paying Stocks
- Seeking Alpha
-
United Therapeutics to acquire priority review voucher for $105M
- Seeking Alpha
-
Healthcare tops premarket gainers list
- Seeking Alpha
-
MannKind to co-promote Thyquidity
- Seeking Alpha
-
MannKind acquires QrumPharma, expands its pipeline
- Seeking Alpha
- Loading more headlines...
Earnings Announcement
Press Releases on MNKD
-
Top Penny Stocks To Buy According To These 3 Analysts
- Penny Stocks
-
Vertice launches THYQUIDITY™ (levothyroxine sodium) Oral Solution
- PR Newswire - PRF
-
4 Top Penny Stocks To Watch For Q1 2021
- Penny Stocks
-
Best Penny Stocks To Buy Right Now? 3 Hot Stocks to Watch
- Penny Stocks
-
3 Top Penny Stocks On Robinhood To Buy Under $3.50
- Penny Stocks
-
MannKind and MidCap Amend Credit Facility
- GlobeNewswire
-
Sabrina Kay Appointed to MannKind Board of Directors
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com